Supriya Lifesci.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE07RO01027
  • NSEID: SUPRIYA
  • BSEID: 543434
INR
610.00
7.35 (1.22%)
BSENSE

Apr 02

BSE+NSE Vol: 1.02 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy
Comparison
Company
Score
Quality
Valuation
Financial
Technical
SMS Pharma.
Senores Pharma.
Shilpa Medicare
Innova Captab
Supriya Lifesci.
Blue Jet Health
Aarti Pharma
FDC
Zota Health Care
SPARC
Sudeep Pharma
Why is Supriya Lifescience Ltd ?
1
High Management Efficiency with a high ROE of 17.74%
2
Company has a low Debt to Equity ratio (avg) at 0 times
3
Poor long term growth as Net Sales has grown by an annual rate of 12.89% and Operating profit at 7.16% over the last 5 years
4
Flat results in Sep 25
5
With ROE of 18.3, it has a Very Expensive valuation with a 6.1 Price to Book Value
  • The stock is trading at a premium compared to its peers' average historical valuations
  • Over the past year, while the stock has generated a return of -6.69%, its profits have risen by 15.8% ; the PEG ratio of the company is 2.1
6
Falling Participation by Institutional Investors
  • Institutional investors have decreased their stake by -0.96% over the previous quarter and collectively hold 10.68% of the company
  • These investors have better capability and resources to analyse fundamentals of companies than most retail investors
stock-recommendationReal-Time Research Report
Verdict Report
How much should you sell?
  1. All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Supriya Lifesci. for you?

High Risk, Low Return

Absolute
Risk Adjusted
Volatility
Supriya Lifesci.
-22.5%
-0.15
44.74%
Sensex
-4.3%
0.44
11.83%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors
Factor
Value
Sales Growth (5y)
11.47%
EBIT Growth (5y)
5.52%
EBIT to Interest (avg)
81.39
Debt to EBITDA (avg)
0.18
Net Debt to Equity (avg)
-0.07
Sales to Capital Employed (avg)
0.70
Tax Ratio
24.90%
Dividend Payout Ratio
4.28%
Pledged Shares
0
Institutional Holding
10.21%
ROCE (avg)
28.52%
ROE (avg)
17.74%
stock-recommendationValuation
Valuation Scorecard stock-summary
stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary
Factor
Value
P/E Ratio
26
Industry P/E
31
Price to Book Value
4.93
EV to EBIT
20.32
EV to EBITDA
18.32
EV to Capital Employed
5.24
EV to Sales
6.58
PEG Ratio
4.15
Dividend Yield
0.16%
ROCE (Latest)
26.04%
ROE (Latest)
18.62%
Loading Valuation Snapshot...
stock-recommendationTechnicals
Technical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bearish
RSI
Bullish
No Signal
Bollinger Bands
Mildly Bearish
Sideways
Moving Averages
Bearish (Daily)
KST
Bearish
Mildly Bearish
Dow Theory
Mildly Bullish
No Trend
OBV
No Trend
No Trend
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend
Financial Trend Scorecard stock-summary
stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

1What is working for the Company
NET SALES(Q)

Highest at Rs 206.44 cr

0What is not working for the Company
Icon
NO KEY NEGATIVE TRIGGERS
Loading Valuation Snapshot...
Here's what is working for Supriya Lifesci.
Net Sales - Quarterly
Highest at Rs 206.44 cr
in the last five quarters
MOJO Watch
Near term sales trend is positive

Net Sales (Rs Cr)